Clinical Trials Logo

Clinical Trial Summary

Oral mucositis (OM) is an acute side effect of radiotherapy for head and neck cancer (HNC). OM associated pain affects oral functions and nutrition of the patient that may result in discontinuity of treatment.The purpose of this clinical study is to evaluate the therapeutic effects of Compound Kushen Injection (CKI) on oral mucositis caused by radiotherapy of head and neck cancer.


Clinical Trial Description

Patients with oral mucositis caused by radiotherapy for Head and Neck Cancer,will be enrolled in the trial, then seprated randomly in two group,the experimental group treated with Levofloxacin injection plus CKI; the contral group treated with Levofloxacin injection only. Clinical grade of radioactive oral mucositis,Oral pain score,Completion and duration of interruption of radiotherapy, Completion of chemotherapy during concurrent chemoradiotherapy,weight change,Food intake (liquid food, semi liquid food),recovery time of oral mucositis will be compared before treatment, 3 days, 5 days and 7 days after treatment between the experimental group and the control group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04204382
Study type Interventional
Source Shanxi Zhendong Pharmacy Co., Ltd
Contact Xin-xin Zhang
Phone 15910520109
Email xinxinzhang66@hotmail.com
Status Recruiting
Phase Phase 4
Start date December 12, 2019
Completion date December 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04110977 - A Reminder App to Reduce Radiation Dermatitis Rates in Patients With Head-and-Neck Cancer N/A
Recruiting NCT05893810 - Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis Phase 3